Cargando…

Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models

Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarke...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Keitaro, Hishinuma, Eiji, Matsukawa, Naomi, Shirasago, Yoshitaka, Watanabe, Masahiro, Sato, Toshihiro, Sato, Yu, Kumondai, Masaki, Kikuchi, Masafumi, Koshiba, Seizo, Fukasawa, Masayoshi, Maekawa, Masamitsu, Mano, Nariyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648601/
https://www.ncbi.nlm.nih.gov/pubmed/37958627
http://dx.doi.org/10.3390/ijms242115642
_version_ 1785135376190406656
author Miyoshi, Keitaro
Hishinuma, Eiji
Matsukawa, Naomi
Shirasago, Yoshitaka
Watanabe, Masahiro
Sato, Toshihiro
Sato, Yu
Kumondai, Masaki
Kikuchi, Masafumi
Koshiba, Seizo
Fukasawa, Masayoshi
Maekawa, Masamitsu
Mano, Nariyasu
author_facet Miyoshi, Keitaro
Hishinuma, Eiji
Matsukawa, Naomi
Shirasago, Yoshitaka
Watanabe, Masahiro
Sato, Toshihiro
Sato, Yu
Kumondai, Masaki
Kikuchi, Masafumi
Koshiba, Seizo
Fukasawa, Masayoshi
Maekawa, Masamitsu
Mano, Nariyasu
author_sort Miyoshi, Keitaro
collection PubMed
description Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarkers and metabolic alterations have been investigated; at present, few comprehensive proteomic alterations have been reported in relation to NPC. In this study, we aimed to elucidate proteomic alterations in NPC and perform a global proteomics analysis for NPC model cells. First, we developed two NPC cell models by knocking out NPC1 using CRISPR/Cas9 (KO1 and KO2). Second, we performed a label-free (LF) global proteomics analysis. Using the LF approach, more than 300 proteins, defined as differentially expressed proteins (DEPs), changed in the KO1 and/or KO2 cells, while the two models shared 35 DEPs. As a bioinformatics analysis, the construction of a protein–protein interaction (PPI) network and an enrichment analysis showed that common characteristic pathways such as ferroptosis and mitophagy were identified in the two model cells. There are few reports of the involvement of NPC in ferroptosis, and this study presents ferroptosis as an altered pathway in NPC. On the other hand, many other pathways and DEPs were previously suggested to be associated with NPC, supporting the link between the proteome analyzed here and NPC. Therapeutic research based on these results is expected in the future.
format Online
Article
Text
id pubmed-10648601
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106486012023-10-27 Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models Miyoshi, Keitaro Hishinuma, Eiji Matsukawa, Naomi Shirasago, Yoshitaka Watanabe, Masahiro Sato, Toshihiro Sato, Yu Kumondai, Masaki Kikuchi, Masafumi Koshiba, Seizo Fukasawa, Masayoshi Maekawa, Masamitsu Mano, Nariyasu Int J Mol Sci Article Niemann–Pick disease type C (NPC) is an autosomal recessive disorder with progressive neurodegeneration. Although the causative genes were previously identified, NPC has unclear pathophysiological aspects, and patients with NPC present various symptoms and onset ages. However, various novel biomarkers and metabolic alterations have been investigated; at present, few comprehensive proteomic alterations have been reported in relation to NPC. In this study, we aimed to elucidate proteomic alterations in NPC and perform a global proteomics analysis for NPC model cells. First, we developed two NPC cell models by knocking out NPC1 using CRISPR/Cas9 (KO1 and KO2). Second, we performed a label-free (LF) global proteomics analysis. Using the LF approach, more than 300 proteins, defined as differentially expressed proteins (DEPs), changed in the KO1 and/or KO2 cells, while the two models shared 35 DEPs. As a bioinformatics analysis, the construction of a protein–protein interaction (PPI) network and an enrichment analysis showed that common characteristic pathways such as ferroptosis and mitophagy were identified in the two model cells. There are few reports of the involvement of NPC in ferroptosis, and this study presents ferroptosis as an altered pathway in NPC. On the other hand, many other pathways and DEPs were previously suggested to be associated with NPC, supporting the link between the proteome analyzed here and NPC. Therapeutic research based on these results is expected in the future. MDPI 2023-10-27 /pmc/articles/PMC10648601/ /pubmed/37958627 http://dx.doi.org/10.3390/ijms242115642 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miyoshi, Keitaro
Hishinuma, Eiji
Matsukawa, Naomi
Shirasago, Yoshitaka
Watanabe, Masahiro
Sato, Toshihiro
Sato, Yu
Kumondai, Masaki
Kikuchi, Masafumi
Koshiba, Seizo
Fukasawa, Masayoshi
Maekawa, Masamitsu
Mano, Nariyasu
Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title_full Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title_fullStr Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title_full_unstemmed Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title_short Global Proteomics for Identifying the Alteration Pathway of Niemann–Pick Disease Type C Using Hepatic Cell Models
title_sort global proteomics for identifying the alteration pathway of niemann–pick disease type c using hepatic cell models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648601/
https://www.ncbi.nlm.nih.gov/pubmed/37958627
http://dx.doi.org/10.3390/ijms242115642
work_keys_str_mv AT miyoshikeitaro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT hishinumaeiji globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT matsukawanaomi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT shirasagoyoshitaka globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT watanabemasahiro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT satotoshihiro globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT satoyu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT kumondaimasaki globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT kikuchimasafumi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT koshibaseizo globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT fukasawamasayoshi globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT maekawamasamitsu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels
AT manonariyasu globalproteomicsforidentifyingthealterationpathwayofniemannpickdiseasetypecusinghepaticcellmodels